Brain Cancer

Brain cancer is a type of cancer that starts in the brain. It's a serious condition that can affect your thoughts, movement, and overall health. Brain cancer can be benign (non-cancerous) or malignant (cancerous). Malignant brain tumors are called brain tumors.

Condition

What people with Brain Cancer report

Every report comes from a Lived member, sent anonymously.

Have you had Craniotomy for Brain Cancer?

NameHow it went

About Brain Cancer

What It Is

A brain tumor is a growth of abnormal cells in or around the brain. "Brain cancer" is the everyday name for these tumors, but not all of them are cancer. Some are benign (noncancerous): they grow slowly and stay contained. Others are malignant: they grow faster and spread into the surrounding brain tissue. Because the skull is rigid and cannot stretch, even a benign tumor can cause serious problems by pressing on the brain, raising pressure inside the head or blocking the fluid that normally flows around it. Tumors that start in the brain or its coverings are called primary brain tumors. They rarely spread outside the brain and spinal cord. Tumors that begin as another cancer, most often lung cancer, and then travel to the brain are called metastatic tumors (brain metastases). These are more common than primary tumors. There are more than 150 types of primary tumor. Meningiomas, which grow from the membranes covering the brain, are the most common and are usually slow-growing and benign. Gliomas grow from the brain's supporting (glial) cells. Glioblastoma is the most common and most aggressive malignant brain tumor in adults. Symptoms depend on where the tumor sits and how fast it grows, because each part of the brain controls different functions. Common signs include headaches that are often worse in the morning or wake a person at night, seizures, nausea and vomiting, weakness or numbness on one side of the body, trouble speaking or understanding words, changes in vision or hearing, poor balance, and changes in memory, concentration, mood or personality. A small tumor may cause no symptoms and be found on a scan done for another reason.

Causes & Risk Factors

Brain tumors form when changes in a cell's genes let it grow and divide out of control. For most people, there is no identifiable reason why that happened, and nothing they did or failed to do caused it. Only a few risk factors are well established. Radiation to the head, such as treatment for an earlier cancer, raises the risk later in life. So do several rare inherited conditions, including neurofibromatosis, Li-Fraumeni syndrome, von Hippel-Lindau disease and tuberous sclerosis. Relatives of someone with one of these syndromes may want genetic counseling. A weakened immune system, for example from HIV (human immunodeficiency virus) infection or medicines taken after an organ transplant, raises the risk of lymphoma that starts in the brain. Exposure to the industrial chemical vinyl chloride has been linked to gliomas. Risk also varies by type and age. Glioblastoma is most common between about 50 and 70, and brain tumors overall are slightly more common in men, while meningiomas are more common in women. Whether heavy cell phone use plays a role has been studied for years and remains unsettled. For metastatic tumors, the main risk factor is having another cancer: up to half come from lung cancer, and breast cancer, kidney cancer and melanoma also commonly spread to the brain.

How It's Diagnosed

Assessment starts with a person's symptoms and a neurological exam, which checks strength, reflexes, coordination, sensation, vision, speech and thinking. If a tumor is suspected, the key test is an MRI (magnetic resonance imaging) scan of the brain, usually with a contrast dye injected into a vein so the tumor shows up more clearly. CT (computed tomography) is an alternative when MRI is not possible. A scan shows a tumor's size and location and whether it looks like a primary tumor or a metastasis, but it usually cannot say exactly what kind of tumor it is. For that, doctors usually need a tissue sample (biopsy). It may be taken through a small hole in the skull with a needle guided by imaging, or during an operation to remove the tumor. A pathologist then identifies the tumor type and grade. Grades run from 1 to 4: grade 1 cells look nearly normal and grow slowly, while grade 4 cells look very abnormal and grow fastest. Unlike most cancers, primary brain tumors are not given a stage, because they rarely spread elsewhere in the body. Gene testing of the tumor is now part of the diagnosis. For example, gliomas with a change in a gene called IDH (isocitrate dehydrogenase) tend to grow more slowly than those without it, and that result can open up specific treatment options. When a tumor sits where a biopsy would be too risky, or a small tumor looks clearly benign on imaging, doctors may decide based on scans alone. If the tumor appears to be a metastasis, testing also looks for the original cancer.

Treatment Options

Treatment depends on the tumor's type, grade, size and location, along with a person's age and overall health. Care is usually planned by a team that includes a neurosurgeon, a radiation oncologist and a neuro-oncologist (a cancer specialist focused on the brain). A small, slow-growing tumor that causes no symptoms, such as many meningiomas, may simply be watched with regular MRI scans, which avoids treatment side effects until treatment is actually needed. When surgery is possible, it is usually the first step. Removing as much tumor as can be taken out safely relieves pressure on the brain and provides tissue for diagnosis. Surgeons map important areas beforehand and can test brain function during the operation to protect speech and movement. Some benign tumors can be removed completely, which may cure them. Gliomas send cells into the surrounding brain, so they cannot be fully removed, and further treatment follows. Radiation therapy is usually given in daily sessions over several weeks to the area of the tumor. Stereotactic radiosurgery, despite its name, involves no incision: it aims a precise, high dose of radiation at a small tumor in one or a few sessions, and is often used for metastases. Chemotherapy is used for many malignant tumors. For glioblastoma, the usual approach after surgery is about six weeks of radiation together with temozolomide (Temodar), a chemotherapy pill, followed by several more months of temozolomide alone. In the trial that established this approach, adding temozolomide added a few months to typical survival. A wearable device that delivers low-intensity electrical fields through patches on the shaved scalp, worn at least 18 hours a day, can be added and improved survival in a trial, though wearing it requires a real daily commitment. Targeted medicines work for tumors with specific gene changes. Vorasidenib (Voranigo), a daily pill, is approved after surgery for grade 2 astrocytomas and oligodendrogliomas with an IDH gene change. It delays tumor growth and postpones the need for radiation or chemotherapy, and it requires regular liver blood tests. It can harm a developing pregnancy. For glioblastoma that returns, options include bevacizumab, an antibody that blocks the blood vessels tumors need to grow, more surgery, further radiation or a different chemotherapy. Clinical trials are a reasonable option at many points, particularly for glioblastoma. Brain metastases are treated with the original cancer in mind. Options include radiosurgery, surgery for a single tumor, radiation to the whole brain, and drugs, since some chemotherapy, immunotherapy and targeted medicines can reach tumors in the brain from certain cancers. Supportive treatment matters at every stage. Corticosteroids (steroid medicines) reduce swelling around a tumor and can ease headaches and restore lost function within hours to days. Antiseizure medicines control seizures. Palliative care, which focuses on symptom relief and emotional support, can be added alongside treatment for both patients and caregivers.

What to Expect

The outlook varies more than for almost any other cancer, because "brain tumor" covers very different diseases. Many benign tumors, including most meningiomas, can be controlled or removed, and some never need treatment at all. People with slower-growing IDH-mutant gliomas often live for many years, and some live more than 10 to 20 years with treatment. Glioblastoma is different: current treatment cannot cure it and it usually returns, but treatment can control it for months or sometimes longer. For brain metastases, outlook depends largely on the original cancer and how well it responds to treatment, and better treatments have extended survival from weeks to years for many people. Daily life can be affected by the tumor itself and by its treatment. Depending on the area involved, people may notice changes in memory, concentration, speech, vision, strength, balance or mood. Some of these improve as swelling settles after surgery or with steroids, while others last. Brain tumors can come back, sometimes many years after treatment, so follow-up MRI scans continue on a regular schedule long after treatment ends. With a malignant tumor, it helps to talk early about goals of care and to put advance directives in place, since the illness can later affect a person's ability to make decisions. Caregivers can get support too, including from palliative care teams.

When to Seek Help

See a clinician about headaches that are new or have changed in pattern, especially ones that are worse in the morning, wake you from sleep, get worse with coughing or straining, or come with vomiting or other neurological symptoms. Most headaches are not caused by brain tumors, but this pattern deserves assessment. The same applies to gradual changes in speech, vision, balance, memory or personality. A first-ever seizure needs medical evaluation the same day. If you are already being treated for a brain tumor, call your care team promptly about new or worsening headaches, new weakness, increasing confusion or a seizure. Call 911 for a seizure that lasts longer than five minutes, or for several seizures without waking up in between. Severe, worsening headache with repeated vomiting, increasing drowsiness, being hard to wake or trouble breathing can signal dangerous pressure inside the skull and also needs emergency care.

Questions to Ask Your Doctor

  1. 1.What type and grade of tumor is this, and what did the gene testing show?
  2. 2.What is the goal of treatment for my tumor, and what are the realistic benefits and trade-offs of each option, including watching it?
  3. 3.How might this tumor or its treatment affect my thinking, speech, movement or independence, and what support is available?
  4. 4.How often will I need scans, and what symptoms should make me call before the next one?
  5. 5.Would a specialized brain tumor center or a clinical trial be worth considering for my situation?

Last reviewed • Oct 2026

Educational content, not medical advice.